{"data":{"type":"feed_item_ai","id":376395,"entity_id":"wefunder:feed_item:376395","attributes":{"canonical_url":"https://wefunder.com/feed/376395","retrieval_urls":{"canonical":"https://wefunder.com/feed/376395","json":"https://wefunder.com/feed/376395.json","markdown":"https://wefunder.com/feed/376395.md","ai_json":"https://wefunder.com/feed/376395.ai.json","ai_text":"https://wefunder.com/feed/376395.ai.txt","changelog_json":"https://wefunder.com/feed/376395.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-08-31T14:08:34.205Z","generated_at":"2026-11-02T05:54:03Z","feed_item":{"id":376395,"entity_id":"wefunder:feed_item:376395","type":"FeedItem::Update","title":"A million-dollar biotech deal just validated something we're sitting on 🧬 | Axiom Biosciences","content_plain":"I want to share a piece of industry news from this week, because it says a lot about where Axiom is headed. Arrowhead Pharmaceuticals just signed a deal to acquire an FDA Priority Review Voucher, a designation that cuts a drug's FDA review time fr...","published_at":"2026-08-29T13:13:43.430Z","updated_at":"2026-08-31T14:08:34.205Z","canonical_url":"https://wefunder.com/feed/376395","image_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MjEyNTg5NywicHVyIjoiYmxvYl9pZCJ9fQ==--748fa48eae950bb02a88063c9f97d131f51d5135/Axiom%20Biosciences-feed-item-376395-cover-photo--cover_photo.jpg","author":{"name":"Remo Moomiaie","profile_url":"https://wefunder.com/remomoomiaie"},"subject":{"name":"Axiom Biosciences","profile_url":"https://wefunder.com/axiombiosciences"}},"key_claims":[{"claim_id":"claim-feed-item-title","text":"Title: A million-dollar biotech deal just validated something we're sitting on 🧬 | Axiom Biosciences","citation":"https://wefunder.com/feed/376395#claim-feed-item-title","observed_at":"2026-08-31T14:08:34Z","expires_at":"2026-09-07T14:08:34Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-08-29 13:13:43 UTC","citation":"https://wefunder.com/feed/376395#claim-feed-item-published-at","observed_at":"2026-08-31T14:08:34Z","expires_at":"2026-09-07T14:08:34Z"}],"verified_facts":[{"claim_id":"claim-feed-item-title","text":"Title: A million-dollar biotech deal just validated something we're sitting on 🧬 | Axiom Biosciences","citation":"https://wefunder.com/feed/376395#claim-feed-item-title","observed_at":"2026-08-31T14:08:34Z","expires_at":"2026-09-07T14:08:34Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-08-29 13:13:43 UTC","citation":"https://wefunder.com/feed/376395#claim-feed-item-published-at","observed_at":"2026-08-31T14:08:34Z","expires_at":"2026-09-07T14:08:34Z"}],"feed_item_claims":{"title":"A million-dollar biotech deal just validated something we're sitting on 🧬 | Axiom Biosciences","content_plain":"I want to share a piece of industry news from this week, because it says a lot about where Axiom is headed. Arrowhead Pharmaceuticals just signed a deal to acquire an FDA Priority Review Voucher, a designation that cuts a drug's FDA review time fr..."},"computed_metrics":{"likes":0,"comments":0,"reposts":0},"relationships":[{"source_entity_id":"wefunder:feed_item:376395","relation":"authored_by","target_url":"https://wefunder.com/remomoomiaie"},{"source_entity_id":"wefunder:feed_item:376395","relation":"posted_to","target_url":"https://wefunder.com/axiombiosciences"}],"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-08-31T14:08:34Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-08-31T14:08:34Z","as_of":"2026-08-31T14:08:34Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-08-31T14:08:34Z","as_of":"2026-08-29T13:13:43Z","confidence":"high"}}}}}}